GNE-220-Hydrochloride - MAP4K 抑制剂 - 生命科学试剂 - MedChemExpress_第1页
GNE-220-Hydrochloride - MAP4K 抑制剂 - 生命科学试剂 - MedChemExpress_第2页
GNE-220-Hydrochloride - MAP4K 抑制剂 - 生命科学试剂 - MedChemExpress_第3页
全文预览已结束

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEGNE 220 HydrochlorideCat. No.: HY-U00428A分式: CHClN分量: 474.99作靶点: MAP4K作通路: MAPK/ERK Pathway储存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性数据体外实验 DMSO : 5.4 mg/mL (11.37 mM; Need ultrasonic)Mass Solvent1

2、 mg 5 mg 10 mg Concentration制备储备液1 mM 2.1053 mL 10.5265 mL 21.0531 mL5 mM 0.4211 mL 2.1053 mL 4.2106 mL10 mM 0.2105 mL 1.0527 mL 2.1053 mL请根据产品在不同溶剂中的溶解度,选择合适的溶剂配制储备液,并请注意储备液的保存式和期限。体内实验 请根据您的实验动物和给药式选择适当的溶解案,配制前请先配制澄的储备液,再依次添加助溶剂(为保证实验结果的可靠性,体内实验的作液,建议您现现配,当天使;澄的储备液可以根据储存条件,适当保存;以下溶剂前的百分 指该溶剂在您配制终溶

3、液中的体积占):1. 请依序添加每种溶剂: 10% DMSO 40% PEG300 5% Tween-80 45% salineSolubility: 0.54 mg/mL (1.14 mM); Clear solution2. 请依序添加每种溶剂: 10% DMSO 90% (20% SBE-CD in saline)Solubility: 0.54 mg/mL (1.14 mM); Clear solution3. 请依序添加每种溶剂: 10% DMSO 90% corn oilSolubility: 0.54 mg/mL (1.14 mM); Clear solution1/2 Mast

4、er of Small Molecules 您边的抑制剂师www.MedChemEBIOLOGICAL ACTIVITY物活性 GNE 220 (Hydrochloride)种有效的选择性 MAP4K4 抑制剂,其 IC50 值为 7 nM。IC50 & Target MAP4K4 MAP4K5 MAP4K6 DMPK7 nM (IC50) 9 nM (IC50) 1.1 M (IC50) 476 nM (IC50)体外研究 GNE-220 also inhibits a few other kinases with IC50s of 9 nM, 476 nM and 1.1 M for MI

5、NK (MAP4K6),DMPK and KHS1 (MAP4K5), respectively. GNE-220 alters human umbilical vein endothelial cells (HUVEC)sprout morphology. GNE-220 also reduces pERM+ retraction fibres in a dose-dependent manner. GNE-220also dose-dependently increased the number of active-INT1+ long focal adhesions (FAs) 1.PR

6、OTOCOLCell Assay 1 HUVECs are cultured in complete EGM-2 (CC-3156 and CC-4176). HUVEC are assayed 3 days after siRNAtransfection. CHO cells are cultured in DMEM supplemented with 10% FBS, 1 mM Glutamate, andPenicillin/Streptomycin and transfected using Lipofectamine LTX. HUVEC sprouting assays are p

7、erformed.For siRNA treatment, HUVECs are transfected 1 day before coating to beads. For chemical inhibitor (e.g.,GNE-220, 0.1, 1, 10, 100, 1000 and 10000 nM) treatment, is added to media after fibrin is clotted. Forimmunofluorescence staining, beads are seeded in thin 100 L fibrin clots. For scratch

8、 wound healing assay,HUVEC are transfected 2 days before re-seeding into a glass-bottom 96-wells plate 1.MCE has not independently confirmed the accuracy of these methods. They are for reference only.REFERENCES1. Vitorino P, et al. MAP4K4 regulates integrin-FERM binding to control endothelial cell motility. Nature. 2015 Mar 26;519(7544):425-30.McePdfHeightCaution: Product has not been fully validated for medical applicatio

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论